CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-07-10. AI was used for research and drafting; the existence of all 4 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 179 · Search date 2026-07-10 · Methodology v1.0

Boron,
does it really help with Bones, joints, and hormones?

30-Second Summary
C
Evidence Grade C · 40 · Safety caution
For joints, the evidence is a calcium fructoborate pilot signal; for testosterone, it is an n=8 short-term surrogate-marker study, so this is at the lower end of C.
What the
research shows
Boron has no RDA as an essential nutrient, and there is also limited consensus on a human clinical deficiency syndrome. There are small studies suggesting that it can change calcium/magnesium metabolism and sex-hormone markers, but evidence directly showing clinical effects on fractures, bone mineral density, joint pain, or hormones is weak.
What the
ads claim
Advertisements mention 'bone mineral density,' 'joints,' 'testosterone,' and 'estrogen balance.' The verifiable evidence is mainly changes in blood and urine markers, and 'hormone enhancement' and 'bone strengthening' should be separated and viewed as closer to D.
*

Useful facts when choosing a product

  • The U.S. adult UL is listed as 20 mg/day.
  • Kidney disease, pregnancy/lactation, and long-term high-dose use require caution.
  • A conservative approach is needed for hormone-sensitive conditions.
  • This should not be interpreted as a clinical effect like osteoporosis drugs or testosterone therapy.
ID

Chamgap Semantic Classification Code

Candidate index · review held

UNK.boron.UNK.bones-joints-and-hormones.assess.UNK

Unknown > Boron > Unknown > Bones, joints, and hormones > Association or change assessment > Unknown

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 179 · C 40
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Boron has no RDA as an essential nutrient, and consensus on a human clinical deficiency syndrome is limited. Nielsen's metabolic studies reported that changes in boron intake may affect calcium/magnesium excretion and some steroid-hormone markers in postmenopausal women. Naghii 2011 administered 10 mg/day for 1 week to 8 healthy men and observed changes in free testosterone, estradiol, and inflammatory markers, but the sample was very small and the endpoints were short-term surrogate markers. Calcium fructoborate joint studies are small pilot signals, and evidence on direct endpoints for fractures or bone mineral density is weak.

02

Why this is classified as C (40)

There are human metabolic-marker and pilot signals, but because there is no RDA, consensus on a deficiency syndrome is limited, and direct clinical endpoints are lacking, the grade is C, 40 points.

Counterpoint. In special diets with low boron intake, separate nutritional assessment may be needed, but the evidence for general efficacy claims is at the lower end of C.

Rejudgment record. Draft — There are human metabolic-marker and pilot signals, but because there is no RDA, consensus on a deficiency syndrome is limited, and direct clinical endpoints are lacking, the grade is C, 40 points.

✓

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Nielsen FH et al. 1987-1990sControlled-diet metabolic studiesPublic/academic, including USDACalcium, magnesium, and hormone metabolic markersChanges in boron intake affected some mineral and hormone markers.Supporting
Naghii MR et al. 2011Short-term human intervention study8UnknownSteroid hormones and inflammatory markersChanges in surrogate markers, including free testosterone, were reported.Supporting
Scorei RI et al. 2011Small pilot studyPossible product involvementJoint pain and CRPSymptom and CRP signals were reported for calcium fructoborate, but size and independence were limited.Supporting
§

Receipt — 4 References

All 4 cited sources were verified for existence at the original page (as of 2026-07-10).

Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour MS. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. J Trace Elem Med Biol. 2011;25:54-58. DOI: 10.1016/j.jtemb.2010.10.001.
checked
Nielsen FH. Update on human health effects of boron. J Trace Elem Med Biol. 2014;28:383-387. DOI: 10.1016/j.jtemb.2014.06.023.
checked
Scorei RI, Mitrut P, Petrisor I, Scorei ID. A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for osteoarthritis patients. Biol Trace Elem Res. 2011.
checked
NIH Office of Dietary Supplements. Boron Fact Sheet for Health Professionals.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-07-10 · Corrections: none
↗

Cite this verdict

Boron × Bones, Joints, and Hormones Evidence Grade C card
[Chamgap] Boron × Bones, Joints, and Hormones — Evidence Grade C·40. 4 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/boron-bone-joint-hormones/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.
↑